-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Amgen, Raises Price Target to $450

Benzinga·08/05/2026 17:16:12
Listen to the news
Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $400 to $450.